Dead cell phagocytosis and innate immune checkpoint

키워드

참고문헌 (49)

1. Bianconi E, "An estimation of the number of cells in the human body", Ann Hum Biol, 40, pp.463~471 (2013)
2. Nagata S, "Autoimmunity and the clearance of dead cells", Cell, 140, pp.619~630 (2010)
3. Green DR, "The clearance of dying cells: table for two", Cell Death Differ, 23, pp.915~926 (2016)
4. Elliott MR, "Clearance of apoptotic cells: implications in health and disease", J Cell Biol, 189, pp.1059~1070 (2010)
5. McIlroy D, "An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes", Genes Dev, 14, pp.549~558 (2000)
6. Lee CS, "Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo", Immunity, 44, pp.807~820 (2016)
7. Sunaga H, "Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice", Nat Commun, 4, pp.2563~ (2013)
8. Poon IK, "Apoptotic cell clearance: basic biology and therapeutic potential", Nat Rev Immunol, 14, pp.166~180 (2014)
9. Ravichandran KS, "Engulfment of apoptotic cells: signals for a good meal", Nat Rev Immunol, 7, pp.964~974 (2007)
10. Lauber K, "Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal", Cell, 113, pp.717~730 (2003)
11. Scott RS, "Phagocytosis and clearance of apoptotic cells is mediated by MER", Nature, 411, pp.207~211 (2001)
12. Yoon KW, "Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53", Science, 349, pp.1261669~ (2015)
13. Bonventre JV, "Cellular pathophysiology of ischemic acute kidney injury", J Clin Invest, 121, pp.4210~4221 (2011)
14. Arandjelovic S, "Phagocytosis of apoptotic cells in homeostasis", Nat Immunol, 16, pp.907~917 (2015)
15. Fond AM, "Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis", Adv Exp Med Biol, 930, pp.25~49 (2016)
16. Elliott MR, "The Dynamics of Apoptotic Cell Clearance", Dev Cell, 38, pp.147~160 (2016)
17. Segawa K, "An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure", Trends Cell Biol, 25, pp.639~650 (2015)
18. van Engeland M, "Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure", Cytometry, 31, pp.1~9 (1998)
19. Segawa K, "Caspasemediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure", Science, 344, pp.1164~1168 (2014)
20. Suzuki J, "Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells", Science, 341, pp.403~406 (2013)
21. Hanayama R, "Identification of a factor that links apoptotic cells to phagocytes", Nature, 417, pp.182~187 (2002)
22. Rothlin CV, "TAM receptor signaling in immune homeostasis", Annu Rev Immunol, 33, pp.355~391 (2015)
23. Freeman GJ, "TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity", Immunol Rev, 235, pp.172~189 (2010)
24. Miyanishi M, "Identification of Tim4 as a phosphatidylserine receptor", Nature, 450, pp.435~439 (2007)
25. Nakayama M, "Tim-3 mediates phagocytosis of apoptotic cells and crosspresentation", Blood, 113, pp.3821~3830 (2009)
26. Kinchen JM, "Phagocytic signaling: you can touch, but you can't eat", Curr Biol, 18, pp.R521~R524 (2008)
27. Chao MP, "Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma", Cell, 142, pp.699~713 (2010)
28. Edris B, "Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma", Proc Natl Acad Sci U S A, 109, pp.6656~6661 (2012)
29. Medina CB, "Do not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes", Cell Death Differ, 23, pp.979~989 (2016)
30. Miyake Y, "Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens", J Clin Invest, 117, pp.2268~2278 (2007)
31. Liu K, "Immune tolerance after delivery of dying cells to dendritic cells in situ", J Exp Med, 196, pp.1091~1097 (2002)
32. Asano K, "CD169- positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens", Immunity, 34, pp.85~95 (2011)
33. Chao MP, "Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47", Sci Transl Med, 2, pp.63~94 (2010)
34. Fujii S, "Antigen mRNAtransfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity", Blood, 113, pp.4262~4272 (2009)
35. Gordon S, "Macrophage heterogeneity in tissues: phenotypic diversity and functions", Immunol Rev, 262, pp.36~55 (2014)
36. Qiu CH, "Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens", J Immunol, 182, pp.4127~4136 (2009)
37. Rovere-Querini P, "HMGB1 is an endogenous immune adjuvant released by necrotic cells", EMBO Rep, 5, pp.825~830 (2004)
38. Dumitriu IE, "Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products", J Immunol, 174, pp.7506~7515 (2005)
39. Yamasaki S, "Mincle is an ITAM-coupled activating receptor that senses damaged cells", Nat Immunol, 9, pp.1179~1188 (2008)
40. Yagai T, "Semaphorin 3E secreted by damaged hepatocytes regulates the sinusoidal regeneration and liver fibrosis during liver regeneration", Am J Pathol, 184, pp.2250~2259 (2014)
41. Gavrieli Y, "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation", J Cell Biol, 119, pp.493~501 (1992)
42. Nonomura K, "Local apoptosis modulates early mammalian brain development through the elimination of morphogen-producing cells", Dev Cell, 27, pp.621~634 (2013)
43. Pasparakis M, "Necroptosis and its role in inflammation", Nature, 517, pp.311~320 (2015)
44. Lamkanfi M, "Mechanisms and functions of inflammasomes", Cell, 157, pp.1013~1022 (2014)
45. Yang WS, "Regulation of ferroptotic cancer cell death by GPX4", Cell, 156, pp.317~331 (2014)
46. Vouri M, "TAM Receptor Tyrosine Kinases in Cancer Drug Resistance", Cancer Res, 77, pp.2775~2778 (2017)
47. Byun DJ, "Cancer immunotherapy-immune checkpoint blockade and associated endocrinopathies", Nat Rev Endocrinol, 13, pp.195~207 (2017)
48. DeRyckere D, "a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models", Clin Cancer Res, 23, pp.1481~1492 (2017)
49. Galluzzi L, "Immunogenic cell death in cancer and infectious disease", Nat Rev Immunol, 17, pp.97~111 (2017)

관련 논문AI추천